SINTX Technologies Announces Closing of $4.0 Million Public Offering
02 févr. 2024 14h33 HE
|
SINTX Technologies, Inc.
SALT LAKE CITY, UT, Feb. 02, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced the...
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
01 févr. 2024 16h22 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
Evaxion Biotech Announces Pricing of $15 Million Public Offering
01 févr. 2024 09h20 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
31 janv. 2024 11h15 HE
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharmaceuticals (Nasdaq: SXTP) closes $2.4 million public offering.
SINTX Technologies Announces Pricing of $4.0 Million Public Offering
31 janv. 2024 09h20 HE
|
SINTX Technologies, Inc.
SALT LAKE CITY, UT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced the...
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
30 janv. 2024 09h00 HE
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharma announces a $2.4 mil public offering, with funds to be used for working capital, relaunching ARAKODA for malaria prevention, and research
Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
25 janv. 2024 20h58 HE
|
Sagimet Biosciences Inc.
SAN MATEO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN)...
Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock
23 janv. 2024 17h45 HE
|
Sagimet Biosciences Inc.
SAN MATEO, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN)...
Genius Group Announces Closing of $8.25 Million Public Offering
17 janv. 2024 11h30 HE
|
Genius Group Limited
SINGAPORE, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, today announced the...
DatChat, Inc. Announces Proposed Underwritten Public Offering of Common Stock
16 janv. 2024 16h05 HE
|
DatChat, Inc.
New Brunswick, NJ, Jan. 16, 2024 (GLOBE NEWSWIRE) -- DatChat, Inc. (Nasdaq: DATS) (“Datchat” or the “Company”), a secure messaging, social media, and metaverse company, today announced that it...